Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for MicroTech Medical (Hangzhou) Co's OCF Yield % or its related term are showing as below:
HKSE:02235'
s OCF Yield % Range Over the Past 10 Years
Min: -10.84 Med: -4.14 Max: 1.26
Current: 1.21
During the past 7 years, the highest OCF Yield % of MicroTech Medical (Hangzhou) Co was 1.26%. The lowest was -10.84%. And the median was -4.14%.
HKSE:02235's OCF Yield % is ranked worse than 51.83% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: 1.63
vs HKSE:02235: 1.21
MicroTech Medical (Hangzhou) Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
MicroTech Medical (Hangzhou) Co OCF Yield % Related Terms
MicroTech Medical (Hangzhou) Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02235 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroTech Medical (Hangzhou) Co OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where MicroTech Medical (Hangzhou) Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MicroTech Medical (Hangzhou) Co (HKSE:02235) has a OCF Yield % of 1.21 as of Aug. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. According to the industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #440 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 51.8%.
Is MicroTech Medical (Hangzhou) Co's OCF Yield % too high?
MicroTech Medical (Hangzhou) Co's current OCF Yield % is 1.21. The Medical Devices & Instruments industry median OCF Yield % is 1.63. MicroTech Medical (Hangzhou) Co's value of 1.21 is 25.8% below this industry median. Based on the distribution chart, MicroTech Medical (Hangzhou) Co ranks #440 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, MicroTech Medical (Hangzhou) Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroTech Medical (Hangzhou) Co's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroTech Medical (Hangzhou) Co ranks #440 out of 849 companies for OCF Yield %. This places MicroTech Medical (Hangzhou) Co in the lower half of its industry. The industry median OCF Yield % is 1.63. MicroTech Medical (Hangzhou) Co's value of 1.21 is 25.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.63, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroTech Medical (Hangzhou) Co's current OCF Yield % of 1.21 is 25.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MicroTech Medical (Hangzhou) Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroTech Medical (Hangzhou) Co's current OCF Yield % is 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroTech Medical (Hangzhou) Co stock overvalued right now?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co (HKSE:02235) is currently considered Possible Value Trap. The stock's GF Value™ is HK$15.94, compared to a current price of HK$7.26 — trading 54.5% below its estimated fair value. The current OCF Yield % is 1.21 and 25.8% below the Medical Devices & Instruments industry median of 1.63. MicroTech Medical (Hangzhou) Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For MicroTech Medical (Hangzhou) Co (HKSE:02235), the current OCF Yield % is 1.21 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroTech Medical (Hangzhou) Co (HKSE:02235) Overvalued in 2026?
Based on GuruFocus' analysis, MicroTech Medical (Hangzhou) Co stock appears to be undervalued.
The current stock price of HK$7.26 is trading 54.5% below its estimated GF Value™ of HK$15.94.
GuruFocus considers MicroTech Medical (Hangzhou) Co to be Possible Value Trap.
Key valuation signals for HKSE:02235:
OCF Yield %: 1.21
GF Value™: HK$15.94 vs. price of HK$7.26 (54.5% below fair value)
Industry Position: 25.8% below the Medical Devices & Instruments median (#440 of 849)
No single metric tells the full story. See the HKSE:02235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroTech Medical (Hangzhou) Co Ltd is focused on diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve the diabetes management in China and globally. The Group operates in a large and fast-growing diabetes monitoring, treatment and management market in China and globally with unmet clinical needs. The company derives a majority of its revenue from China.
80GF Score
Get the complete analysis for HKSE:02235
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02235 has been successfully added to your 
